Evidence map›Paper›PMID 40654983›Full record

ArticlebioRxiv : the preprint server for biology2025

A Platform for Mitochondrial Profiling in Enriched Kidney Segments Under Thermodynamic Control.

Stephen T Decker, Precious C Opurum, Ran Hee Choi, Venisia L Paula, Anu S Kurian, Deborah Stuart, Linda S Nikolova, Alejandro Sanchez, Laith Al-Rabadi, Nirupama Ramkumar and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephen T DeckerDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.ORCID 0000-0001-5867-1294
Precious C OpurumDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.ORCID 0000-0001-6220-9430
Ran Hee ChoiDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.ORCID 0000-0001-9002-2657
Venisia L PaulaDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.
Anu S KurianDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.
Deborah StuartDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah.
Linda S NikolovaElectron Microscopy Core Facility; University of Utah; Salt Lake City, UT; USA.
Alejandro SanchezDivision of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Laith Al-RabadiDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah.
Nirupama RamkumarDivision of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0002-5312-1100
Kelsey H Fisher-WellmanDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0002-0300-829X
Katsuhiko FunaiDiabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-3802-4756

Funding

Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
PE methylation in skeletal muscle energy efficiencyR01DK107397 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI FUNAI, KATSUHIKO · 2017 to 2025
$3.8M
LOOH-induced muscle atrophy with ageR01AG074535 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Micah J Drummond, Katsuhiko Funai · 2022 to 2026
$3.0M
Lands cycle and skeletal muscle insulin actionR01DK127979 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI FUNAI, KATSUHIKO · 2022 to 2025
$1.9M
Soluble (pro)renin receptor regulation of kidney fibrosisR01DK133271 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI NIRUPAMA RAMKUMAR · 2023 to 2026
$1.8M
Mitochondrial bioenergetics and colorectal cancerR37CA278826 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Kelsey H Fisher-Wellman · 2024 to 2026
$1.6M
PE In Modulation of Energy Flux Through OxphosR01GM144613 · NIGMS · UNIVERSITY OF UTAH · PI FUNAI, KATSUHIKO · 2021 to 2024
$1.6M
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen EpitopesK23DK132487 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Laith Al-Rabadi · 2023 to 2026
$701k
NCI NIH HHS R37 CA278826NIA NIH HHS R01 AG074535NIDDK NIH HHS K23 DK132487NIDDK NIH HHS R01 DK107397NIDDK NIH HHS R01 DK127979NIDDK NIH HHS R01 DK133271NIDDK NIH HHS T32 DK091317NIGMS NIH HHS R01 GM144613
6 · The paper itself

Abstract

Mitochondrial function varies widely across kidney nephron segments, yet conventional approaches lack the resolution and control needed to assess cell-type-specific bioenergetics in situ. We present a methodological platform that enables segment-resolved profiling of mitochondrial respiration, conductance, and membrane potential in freshly isolated mouse nephron segments. Combining mechanical sieving and adhesion-based enrichment with permeabilized high-resolution respirometry, we adapted the creatine kinase clamp to quantify oxygen flux and mitochondrial membrane potential across defined free energies. Using this approach, we found that proximal tubules exhibit high respiratory conductance and dynamic mitochondrial polarization, while distal tubules and glomeruli maintain static membrane potential and low conductance. In a model of adenine-induced nephropathy, only proximal tubule mitochondria showed marked reductions in respiration and ATP production. This segment-specific dysfunction was not detectable in bulk mitochondrial isolates. Our approach provides thermodynamically anchored, segment-resolved insight into mitochondrial adaptation under physiological and pathological conditions. It is broadly applicable to other tissues with metabolic heterogeneity and compatible with disease models, genetic tools, and pharmacological interventions. This platform bridges a critical gap between conventional respirometry and functional mitochondrial phenotyping in native tissue structures.

Identifiers

PMID40654983
PMCPMC12248031

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.